Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniques.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Current Opinion in Lipidology

• Publication date

  1999-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00041433-199912000-00012PMID 10680051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood.

  2008cited by this paper
• Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits.

  1999cited by this paper
• Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase– ganciclovir treatment

  1999cited by this paper
• Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation.

  1999cited by this paper
• Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.

  1999cited by this paper
• Drug treatment of lipid disorders.

  1999cited by this paper
• Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.

  1999cited by this paper
• DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results

  1998cited by this paper
• Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.

  1998cited by this paper
• A novel low‐density lipoprotein apheresis device for removal of atherogenic lipoproteins from whole blood

  1998cited by this paper
• Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia

  1998cited by this paper
• Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.

  1998cited by this paper
• Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.

  1998cited by this paper
• Safety and effectiveness of long-term LDL-apheresis in patients at high risk.

  1998cited by this paper
• Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.

  1998cited by this paper
• Treatment of hypercholesterolemia with heparin‐induced extracorporeal low‐density lipoprotein precipitation (HELP)

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Perception of quality of life before and after disclosure of trial results: a report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).

  1993cited by this paper
• Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

  1993cited by this paper
• Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

  1990cited by this paper
• Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

  1990cited by this paper
• Reduction of low‐density lipoproteins with dextran sulfate in patients with familial hypercholesterolemia

  1988cited by this paper
• Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical application.

  1986cited by this paper
• Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.

  1985cited by this paper
• Selective Removal of Low Density Lipoprotein by Plasmapheresis in Familial Hypercholesterolemia

  1985cited by this paper
• The effect of portacaval shunt on hepatic lipoprotein metabolism in familial hypercholesterolemia.

  1985cited by this paper
• Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia.

  1984cited by this paper
• Treatment of frostbite with guanethidine.

  1981cited by this paper
• Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia.

  1981cited by this paper
• Failure of complete bile diversion and oral bile acid therapy in the treatment of homozygous familial hypercholesterolemia.

  1977cited by this paper
• A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography.

  1976cited by this paper
• Effects of intravenous hyperalimentation of plasma-lipoproteins in severe familial hypercholesterolaemia.

  1975cited by this paper
• Plasma exchange in the management of homozygous familial hypercholesterolaemia.

  1975cited by this paper
• EFFECTS OF INTRAVENOUS HYPERALIMENTATION ON PLASMA-LIPOPROTEINS IN SEVERE FAMILIAL HYPERCHOLESTEROLÆMIA

  1975cited by this paper
• Portacaval shunt in hyperlipoproteinaemia.

  1973cited by this paper
• [Homozygous cutaneo-tendinous forms of hypercholesteremic xanthomatosis in an exemplary familial case. Trial of plasmapheresis ans heroic treatment].

  1967cited by this paper
• PROTECTION AGAINST RUBELLA

  1965cited by this paper
• Lowering of Cholesterol Absorption and Blood Levels by Ileal Exclusion: Experimental Basis and Preliminary Clinical Report

  1964cited by this paper
• FRACTURE OF THE FEMORAL NECK.

  1964cited by this paper

• Atherosclerosis: Pathogenesis, Clinical Features and Treatment

  2007cites this paper
• Long-term follow-up of a patient with hypercholesterolaemia treated by liver transplantation.

  2007cites this paper
• Genetics of Ischemic Heart Disease

  2007cites this paper
• Comparison of two filter combinations for low-density lipoprotein apheresis by membrane differential filtration: a prospective crossover controlled clinical study.

  2002cites this paper
• The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.

  2002cites this paper
• Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial.

  2000cites this paper